FDA Inspection 1051600 — University Of Texas MD Anderson Cancer Center
The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on May 2, 2018 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 2, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)